These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 27758791)

  • 1. Diabetes prescribing rises by a third over five years.
    Torjesen I
    BMJ; 2016 Oct; 355():i5484. PubMed ID: 27758791
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug Combo Adds No Benefit in Patients with Type 2 Diabetes.
    Geurin MD
    Am Fam Physician; 2016 Mar; 93(6):436-8. PubMed ID: 26977827
    [No Abstract]   [Full Text] [Related]  

  • 3. Sitagliptin in type 2 diabetes mellitus: Efficacy after five years of therapy.
    Derosa G; D'Angelo A; Maffioli P
    Pharmacol Res; 2015 Oct; 100():127-34. PubMed ID: 26211947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy.
    Inzucchi SE; Tunceli K; Qiu Y; Rajpathak S; Brodovicz KG; Engel SS; Mavros P; Radican L; Brudi P; Li Z; Fan CP; Hanna B; Tang J; Blonde L
    Diabetes Obes Metab; 2015 Oct; 17(10):956-64. PubMed ID: 25962401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing of metformin based on estimated GFR rather than serum creatinine expands the eligible population and is likely safe.
    Castelino RL; Peterson G
    Evid Based Med; 2016 Apr; 21(2):68. PubMed ID: 26786825
    [No Abstract]   [Full Text] [Related]  

  • 6. Sitagliptin for Type 2 diabetes: a 2015 update.
    Lee M; Rhee MK
    Expert Rev Cardiovasc Ther; 2015 Jun; 13(6):597-610. PubMed ID: 26000559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixed dose combination diabetes medicines - usage in the Australian veteran population.
    Gadzhanova S; Gillies M; Roughead E; Zuo Y
    Aust Fam Physician; 2011 Oct; 40(10):811-5. PubMed ID: 22003487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sitagliptin with metformin: profile of a combination for the treatment of type 2 diabetes.
    Gallwitz B
    Drugs Today (Barc); 2007 Oct; 43(10):681-9. PubMed ID: 17987221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes: Metformin and renal insufficiency-is 45, or even 30, the new 60?
    Bloomgarden Z
    Nat Rev Endocrinol; 2015 Dec; 11(12):693-4. PubMed ID: 26416220
    [No Abstract]   [Full Text] [Related]  

  • 10. An Evidence Based Study on Comparison of Adverse Drug Reactions of Metformin & Sitagliptin with their Combination.
    Dalal K; Gor A; Ganguly B
    Indian J Physiol Pharmacol; 2016 Apr; 60(2):213-214. PubMed ID: 29809381
    [No Abstract]   [Full Text] [Related]  

  • 11. Metformin as Initial Oral Therapy in Type 2 Diabetes.
    Stern RJ; Murphy EJ
    JAMA; 2015 Jun 23-30; 313(24):2484-5. PubMed ID: 26103032
    [No Abstract]   [Full Text] [Related]  

  • 12. Sitagliptin/metformin (Janumet) for type 2 diabetes.
    Med Lett Drugs Ther; 2007 Jun; 49(1262):45-7. PubMed ID: 17541377
    [No Abstract]   [Full Text] [Related]  

  • 13. [Type 2 diabetes: Metformin: first choice at the start of therapy].
    Gallwitz B
    Dtsch Med Wochenschr; 2015 Feb; 140(4):236. PubMed ID: 25704514
    [No Abstract]   [Full Text] [Related]  

  • 14. The epidemic of type 2 diabetes is a statistical artefact.
    Green A; Støvring H; Andersen M; Beck-Nielsen H
    Diabetologia; 2005 Aug; 48(8):1456-8. PubMed ID: 15988576
    [No Abstract]   [Full Text] [Related]  

  • 15. Initial therapy for diabetes mellitus.
    Segal JB; Maruthur NM
    JAMA Intern Med; 2014 Dec; 174(12):1962-3. PubMed ID: 25347083
    [No Abstract]   [Full Text] [Related]  

  • 16. Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: A population-based case-control study in Taiwan.
    Liao KF; Lin CL; Lai SW; Chen WC
    Eur J Intern Med; 2016 Jan; 27():76-9. PubMed ID: 26433909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of initial treatment with glimpeiride versus sitagliptin in type 2 diabetes].
    Tamez-Pérez HE;
    Rev Med Inst Mex Seguro Soc; 2015; 53(2):142-8. PubMed ID: 25760742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case of Sitagliptin-Induced Mild Acute Pancreatitis.
    Kocak MZ; Aktas G; Erkus E; Duman TT; Atak BM; Sahin D; Savli H
    J Coll Physicians Surg Pak; 2018 Apr; 28(4):334. PubMed ID: 29615184
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care.
    Hippisley-Cox J; Coupland C
    BMJ; 2016 Jul; 354():i3477. PubMed ID: 27413012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metformin in type 2 diabetes: what if we get it wrong?].
    Boussageon R
    Presse Med; 2013 Feb; 42(2):132-3. PubMed ID: 23159535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.